NanoString Technologies Completes Series E

By Angela Sormani — 3 years ago

NanoString Technologies, a provider of life science tools for translational research and developer of molecular diagnostic products, has completed a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. All previous venture investors participated including Clarus Ventures, Draper Fisher Jurvetson, OVP Venture Partners, GE healthymagination Fund, BioMed Ventures, and Henri Termeer.


Check-Cap Gets GE Backing

By Angela Sormani — 4 years ago

GE Capital and GE Healthcare, the financial services and healthcare divisions of General Electric Company have invested in Check-Cap, a developer of an ingestible imaging capsule that may help detect colorectal cancer. The investment is being made through the GE healthymagination Fund, an equity fund that makes investments in healthcare technology companies. PRESS RELEASE GE […]